Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing.

PubWeight™: 1.06‹?› | Rank: Top 10%

🔗 View Article (PMC 4136146)

Published in J Clin Microbiol on May 28, 2014

Authors

Jerod L Nagel1, Angela M Huang2, Anjly Kunapuli3, Tejal N Gandhi4, Laraine L Washer5, Jessica Lassiter3, Twisha Patel3, Duane W Newton6

Author Affiliations

1: Department of Pharmacy Services and Clinical Sciences, University of Michigan Health System and College of Pharmacy, Ann Arbor, Michigan, USA nageljl@med.umich.edu.
2: Department of Pharmacy Services and Clinical Sciences, University of Michigan Health System and College of Pharmacy, Ann Arbor, Michigan, USA Froedtert Hosptial and The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
3: Department of Pharmacy Services and Clinical Sciences, University of Michigan Health System and College of Pharmacy, Ann Arbor, Michigan, USA.
4: Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Health System and Medical School, Ann Arbor, Michigan, USA.
5: Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Health System and Medical School, Ann Arbor, Michigan, USA Department of Infection Control and Epidemiology, University of Michigan Health System and Medical School, Ann Arbor, Michigan, USA.
6: Clinical Microbiology Laboratories and Department of Pathology, University of Michigan Health System and Medical School, Ann Arbor, Michigan, USA.

Articles citing this

Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial. J Clin Microbiol (2016) 1.02

Rapid molecular diagnostic tests in patients with bacteremia: evaluation of their impact on decision making and clinical outcomes. Eur J Clin Microbiol Infect Dis (2015) 0.95

Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials. Antibiotics (Basel) (2016) 0.84

Survey of physicians' perspectives and knowledge about diagnostic tests for bloodstream infections. PLoS One (2015) 0.84

Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship Programs. Infect Dis Rep (2017) 0.79

The Confounding Role of Antimicrobial Stewardship Programs in Understanding the Impact of Technology on Patient Care. J Clin Microbiol (2016) 0.79

Cost Analysis of Implementing MALDI-TOF plus Real-time Antimicrobial Stewardship Intervention for Bloodstream Infections. J Clin Microbiol (2016) 0.78

Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship. Clin Microbiol Rev (2016) 0.78

Applicability of an in-House Saponin-Based Extraction Method in Bruker Biotyper Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry System for Identification of Bacterial and Fungal Species in Positively Flagged Blood Cultures. Front Microbiol (2016) 0.75

The Added Cost of Rapid Diagnostic Testing and Active Antimicrobial Stewardship, Is It Worth It? J Clin Microbiol (2016) 0.75

A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures. Infect Dis Ther (2016) 0.75

Time to Detection with BacT/Alert FA Plus Compared to BacT/Alert FA Blood Culture Media. Eur J Clin Microbiol Infect Dis (2016) 0.75

Articles cited by this

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control (2008) 24.70

Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol (2012) 6.27

Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2009) 3.54

Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol (2009) 3.45

Rapid identification of Staphylococcus aureus directly from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes. J Clin Microbiol (2002) 3.40

Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J Clin Microbiol (2012) 2.80

Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med (2012) 2.62

Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis (2013) 2.53

Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis (2012) 2.17

Evaluation of a microarray-based assay for rapid identification of Gram-positive organisms and resistance markers in positive blood cultures. J Clin Microbiol (2013) 1.93

Direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry improves appropriateness of antibiotic treatment of bacteremia. PLoS One (2012) 1.84

Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag (2008) 1.79

Identification of blood culture isolates directly from positive blood cultures by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and a commercial extraction system: analysis of performance, cost, and turnaround time. J Clin Microbiol (2012) 1.59

Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital. J Clin Microbiol (2008) 1.26

Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J Clin Microbiol (2011) 1.25

Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother (2012) 1.18

True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants. Eur J Clin Microbiol Infect Dis (2012) 0.96